MAM
Aman Dhall quits Policybazaar, starts his own venture
NEW DELHI: PolicyBazaar.com head of corporate communications Aman Dhall has resigned from the company after a stint of more than six years. He will soon start his new venture in the content and communications space, he announced on LinkedIn.
“I have had a fantastic time during my six-year journey here, building its communications function from scratch, and leading storytelling through its growth from the valuation of 100mn$ to 1.65bn$,” Dhall wrote in the LinkedIn post.
He looked back proudly on the platform’s impact in generating awareness around death, disease, and disability products, and the narrative of 'Insurance for Protection'.
“I want to thank you all for your support during my innings here! Look forward to the similar support, as I embark on a new journey,” he said.
Dhall identifies himself as a proud intrapreneur, and has also had an entrepreneurial stint prior to PolicyBazaar, where he established and ran a not-for-profit venture in the sport and development space for three years.
He carries over 15 years of experience in media, financial services, consumer internet and development sector, and has worked in editorial, communications and advocacy roles with influential brands such as the Times of India group, UNICEF, SEDA, and Magic Bus India Foundation.
MAM
Beacon Group appoints Dr Rajesh Patel as Group CEO
36-year healthcare veteran to lead Beacon Diagnostics, Vector Biotek, Biogeny.
MUMBAI: A new chief, a fresh diagnosis and a sharper prescription for growth. Beacon Group has appointed Dr Rajesh Patel as its Group Chief Executive Officer, effective April 1, 2026, signalling a decisive push to scale its presence in the diagnostics and IVD space. Patel steps into the role with 36 years of experience across the healthcare and diagnostics industry, bringing a career shaped by leadership roles spanning sales, marketing, business development and operational strategy. His mandate is both expansive and precise: to steer the group’s overall strategic direction while tightening coordination across its three core entities Beacon Diagnostics, Vector Biotek and Biogeny Diagnostics.
In practical terms, that means driving cross-company synergies, accelerating market expansion and strengthening organisational capability areas increasingly critical as diagnostic players compete for scale in a fragmented yet rapidly evolving healthcare ecosystem. The group is positioning itself to capture unmet demand across chain laboratories, key accounts and standalone labs, segments that remain underserved despite growing diagnostic needs.
The appointment comes at a time when the In Vitro Diagnostics (IVD) sector in India is entering a more competitive and innovation-led phase, with companies focusing not just on product pipelines but also on service delivery, integration and customer-centric models. Beacon’s leadership appears to be betting that Patel’s execution-focused approach can help translate ambition into operational momentum.
Welcoming the appointment, Chairman Dr D K Joshi described Patel’s induction as a strategic move aligned with the group’s long-term vision, emphasising the role of leadership depth in navigating the next phase of growth.
For Beacon Group, the message is clear, in a sector where precision matters, leadership is the new differentiator—and this appointment is intended to set the tone for what comes next.
